Gene expression in human mesenchymal stem cell aging cultures: modulation by short peptides
Lab research · 2020
- What was studied
- Human embryonic bone-marrow MSC line FetMSCs, aged in culture
- Main finding
- AED, KED and KE changed expression of selected aging-related genes. Effects depended on peptide and culture-aging model; KED affected TNKS2 in opposite directions across models.
Study data at a glance
- Participants or experimental model
- Human embryonic bone-marrow MSC line FetMSCs, aged in culture
- Reported results
- AED, KED and KE changed expression of selected aging-related genes. Effects depended on peptide and culture-aging model; KED affected TNKS2 in opposite directions across models.
Study limitations and source details
Study limitations
- Human-derived cells are not human clinical participants.
- Gene-expression changes do not establish improved cartilage repair, slower aging or safety.
Source details
Indexed abstract and citation checked via Europe PMC / PubMed; full methods and risk of bias not appraised.
Sources checked
Citation
Author affiliations · St. Petersburg Institute of Bioregulation and Gerontology
Ashapkin V, Khavinson V, Shilovsky G, Linkova N, Vanuyshin B. Gene expression in human mesenchymal stem cell aging cultures: modulation by short peptides Mol Biol Rep 47(6):4323-4329. PMID 32399807
Study source ↗ · DOI 10.1007/s11033-020-05506-3 · Bibliography entry · Link to this summary
Related compounds
Cartalax
A synthetic tripeptide, Ala–Glu–Asp (AED, also called T-31), studied in cartilage, bone and joint research. Some related experiments used a cartilage extract containing AED.
Vilon
A synthetic two-amino-acid peptide (Lys–Glu, or KE) studied in thymus, immune and tissue-repair research.
Vesugen
A synthetic three-amino-acid peptide (Lys–Glu–Asp, or KED) studied in vascular and cell-aging research.
KED
A three-amino-acid peptide (Lys–Glu–Asp) studied in vascular and nerve-cell research and catalogued as Vesugen.